Local Administration of Mesenchymal Stromal Cells Is Safe and Modulates the Immune Compartment in Ulcerative Proctitis

Scientists reported on a Phase IIa clinical study that evaluated the impact of local MSC therapy on ulcerative proctitis (UP). 13 refractory UP patients, with an endoscopic Mayo score of 2 or 3, were included.